English | Español

Biospace
Patient Daily | Feb 11, 2026

Eli Lilly acquisition highlights surge in interest for in vivo gene therapies
Patient Daily | Feb 11, 2026

Pelage Pharmaceuticals advances stem cell-based therapy for pattern hair loss
Patient Daily | Feb 10, 2026

Amgen ends partnership with Kyowa Kirin on autoimmune drug rocatinlimab
Patient Daily | Feb 10, 2026

FDA flagged key issues early before rejecting Corcept’s hypercortisolism drug
Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue
Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures